| Product Code: ETC9976931 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States saw a significant increase in specialty lancets import shipments in 2024, with Mexico, Taiwan, Italy, Israel, and Switzerland emerging as the top exporters. The market concentration, as measured by HHI, shifted from low to moderate, indicating a more balanced distribution among countries. The impressive Compound Annual Growth Rate (CAGR) of 14.68% from 2020 to 2024, coupled with a growth rate of 16.06% from 2023 to 2024, underscores the growing demand for specialty lancets in the US market. This trend signifies potential opportunities for market expansion and diversification in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Specialty Lancets Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Specialty Lancets Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Specialty Lancets Market - Industry Life Cycle |
3.4 United States (US) Specialty Lancets Market - Porter's Five Forces |
3.5 United States (US) Specialty Lancets Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 United States (US) Specialty Lancets Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 United States (US) Specialty Lancets Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.8 United States (US) Specialty Lancets Market Revenues & Volume Share, By Products, 2021 & 2031F |
4 United States (US) Specialty Lancets Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in the US leading to higher demand for lancets |
4.2.2 Technological advancements in lancet devices improving accuracy and ease of use |
4.2.3 Rising adoption of self-monitoring of blood glucose levels among diabetic patients |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for lancet devices leading to increased time and cost for product approvals |
4.3.2 Competition from alternative methods of blood glucose monitoring such as continuous glucose monitoring systems |
5 United States (US) Specialty Lancets Market Trends |
6 United States (US) Specialty Lancets Market, By Types |
6.1 United States (US) Specialty Lancets Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Specialty Lancets Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 United States (US) Specialty Lancets Market Revenues & Volume, By Blood Glucose Testing, 2021- 2031F |
6.1.4 United States (US) Specialty Lancets Market Revenues & Volume, By Hemoglobin Testing, 2021- 2031F |
6.1.5 United States (US) Specialty Lancets Market Revenues & Volume, By Cholesterol Testing, 2021- 2031F |
6.1.6 United States (US) Specialty Lancets Market Revenues & Volume, By Coagulation Testing, 2021- 2031F |
6.1.7 United States (US) Specialty Lancets Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Specialty Lancets Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Specialty Lancets Market Revenues & Volume, By Length Under 1mm, 2021- 2031F |
6.2.3 United States (US) Specialty Lancets Market Revenues & Volume, By Length 1-1.5mm, 2021- 2031F |
6.2.4 United States (US) Specialty Lancets Market Revenues & Volume, By Length 1.5-2mm, 2021- 2031F |
6.2.5 United States (US) Specialty Lancets Market Revenues & Volume, By Length Above 2mm, 2021- 2031F |
6.3 United States (US) Specialty Lancets Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Specialty Lancets Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Specialty Lancets Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 United States (US) Specialty Lancets Market Revenues & Volume, By Home Care, 2021- 2031F |
6.3.5 United States (US) Specialty Lancets Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Specialty Lancets Market, By Products |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Specialty Lancets Market Revenues & Volume, By Safety Lancets, 2021- 2031F |
6.4.3 United States (US) Specialty Lancets Market Revenues & Volume, By Standard Lancets, 2021- 2031F |
6.4.4 United States (US) Specialty Lancets Market Revenues & Volume, By Specialty Lancets, 2021- 2031F |
7 United States (US) Specialty Lancets Market Import-Export Trade Statistics |
7.1 United States (US) Specialty Lancets Market Export to Major Countries |
7.2 United States (US) Specialty Lancets Market Imports from Major Countries |
8 United States (US) Specialty Lancets Market Key Performance Indicators |
8.1 Average selling price of specialty lancets in the US market |
8.2 Number of new product launches and innovations in lancet devices |
8.3 Adoption rate of specialty lancets among healthcare providers and diabetic patients |
9 United States (US) Specialty Lancets Market - Opportunity Assessment |
9.1 United States (US) Specialty Lancets Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 United States (US) Specialty Lancets Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 United States (US) Specialty Lancets Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.4 United States (US) Specialty Lancets Market Opportunity Assessment, By Products, 2021 & 2031F |
10 United States (US) Specialty Lancets Market - Competitive Landscape |
10.1 United States (US) Specialty Lancets Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Specialty Lancets Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |